Charming Medical Ltd

MCTA

LOS ANGELES, Feb. 13, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charming Medical Limited ("Charming" or "the Company") (NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 21, 2025, and November 12, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before February 17, 2026.

LOS ANGELES, Feb. 12, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Charming Medical Limited ("Charming " or "the Company") (NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MCTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

NEW YORK, Feb. 12, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Charming Medical Ltd. ("Charming" or the "Company") (NASDAQ: MCTA).

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming February 17, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Charming Medical Limited (“Charming” or the “Company”) (NASDAQ: MCTA) securities between October 10, 2025 and November 12, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CHARMING MEDICAL LIMITED (MCTA), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PA.

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming February 17, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Charming Medical Limited (“Charming” or the “Company”) (NASDAQ: MCTA) securities between October 10, 2025 and November 12, 2025, inclusive (the “Class Period”). What Happened? On November 11, 2025, after market hours, the SEC issued an order to halt tra.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming February 17, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Charming Medical Limited (“Charming” or the “Company”) (NASDAQ: MCTA) securities between October 10, 2025 and November 12, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR CHARMING INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY.

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Charming (MCTA) To Contact Him Directly To Discuss Their Options

LOS ANGELES, Feb. 9, 2026 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charming Medical Limited ("Charming" or "the Company") (NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 21, 2025, and November 12, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before February 17, 2026.

LOS ANGELES, Feb. 9, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against  Charming Medical Limited ("Charming " or "the Company") (NASDAQ: MCTA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MCTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

New class action for Charming (MCTA) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/17/2026.